These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9200279)

  • 21. Clinical evaluation of the effect of omeprazole, cimetidine, famotidine and ranitidine on histamine induced cutaneous wheal and flare response.
    Saha N; Sachdev A; Bhasin DK; Sankaranahyanan A; Khosla PP; Singh K; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):322-5. PubMed ID: 8103763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastro-oesophageal reflux disease in The Netherlands. Results of a multicentre pH study.
    Smout AJ; Geus WP; Mulder PG; Stockbrügger RW; Lamers CB
    Scand J Gastroenterol Suppl; 1996; 218():10-5. PubMed ID: 8865445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
    Richter JE; Campbell DR; Kahrilas PJ; Huang B; Fludas C
    Arch Intern Med; 2000 Jun; 160(12):1803-9. PubMed ID: 10871974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Famotidine for infant gastro-oesophageal reflux: a multi-centre, randomized, placebo-controlled, withdrawal trial.
    Orenstein SR; Shalaby TM; Devandry SN; Liacouras CA; Czinn SJ; Dice JE; Simon TJ; Ahrens SP; Stauffer LA
    Aliment Pharmacol Ther; 2003 May; 17(9):1097-107. PubMed ID: 12752346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease.
    Wada T; Sasaki M; Kataoka H; Tanida S; Itoh K; Ogasawara N; Oshima T; Togawa S; Kubota E; Yamada T; Mori Y; Fujita F; Ohara H; Nakao H; Sobue S; Joh T; Itoh M
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():2-9. PubMed ID: 15943840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Symptomatic therapy with famotidine in non-erosive gastro-esophageal reflux. Results of an open multicenter study].
    Heckers H; Lübbecke F
    Arzneimittelforschung; 1995 Apr; 45(4):499-504. PubMed ID: 7779150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of 40 mg famotidine nightly and 150 mg ranitidine b.d.: ulcer healing and symptom relief in benign gastric ulcer.
    Cochran KM; Cockel R; Crowe J; Dickinson RJ; Gent AE; Kennedy NP; Royston CM; Cedar E; Mann SG
    Aliment Pharmacol Ther; 1989 Oct; 3(5):461-70. PubMed ID: 2518859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of active duodenal ulcers with famotidine. A double-blind comparison with ranitidine.
    Rohner HG; Gugler R
    Am J Med; 1986 Oct; 81(4B):13-6. PubMed ID: 2877569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Control of intragastric acidity with over-the-counter doses of ranitidine or famotidine.
    Hamilton MI; Sercombe J; Pounder RE
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1579-83. PubMed ID: 11563997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Famotidine (20 mg) b.d. relieves gastrooesophageal reflux symptoms in patients without erosive oesophagitis. Famotidine/GERD Investigation Group.
    Robinsen M; Decktor DL; Stone RC; Pevelery M; Barden P; Moyer R; Holt S; Root J; Hufnagel K; Humphries TJ
    Aliment Pharmacol Ther; 1991 Dec; 5(6):631-43. PubMed ID: 1782306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, double-blind, placebo-controlled clinical study of the histamine H2-receptor antagonist famotidine in Japanese patients with nonerosive reflux disease.
    Hongo M; Kinoshita Y; Haruma K
    J Gastroenterol; 2008; 43(6):448-56. PubMed ID: 18600389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro effects of famotidine and ranitidine on lower esophageal sphincter tone in rats.
    Özer M; Duman M; Taş Ş; Demırcı Y; Aydin MF; Reyhan E; Atici AE; Bostanci EB; Akoğlu M; Genç E
    Turk J Gastroenterol; 2012; 23(5):438-43. PubMed ID: 23161288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP; Schenk E; Tan G; Snel P; Nelis F
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic review: the efficacy of intermittent and on-demand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients.
    Zacny J; Zamakhshary M; Sketris I; Veldhuyzen van Zanten S
    Aliment Pharmacol Ther; 2005 Jun; 21(11):1299-312. PubMed ID: 15932360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ranitidine suspension or famotidine resoriblette and gastric fluid volume and pH.
    Oikkonen M; Erkola O; Collan R
    Can J Anaesth; 1995 Sep; 42(9):793-6. PubMed ID: 7497560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A controlled study of 20 mg famotidine nocte vs. 150 mg ranitidine nocte for the prevention of duodenal ulcer relapse.
    Bianchi Porro G; Lazzaroni M; Barbara L; Corinaldesi R; Blasi A; Mangiameli A; Capurso L; Koch M; Cheli R; Bovero E
    Aliment Pharmacol Ther; 1991 Apr; 5(2):181-9. PubMed ID: 1888818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative effectiveness of histamine-2 receptor antagonists as short-term therapy for gastro-esophageal reflux disease: a network meta-analysis.
    Zhao F; Wang S; Liu L; Wang Y
    Int J Clin Pharmacol Ther; 2016 Oct; 54(10):761-70. PubMed ID: 27443665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Onset of relief of symptoms of gastroesophageal reflux disease: post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily.
    Haag S; Holtmann G
    Clin Ther; 2010 Apr; 32(4):678-90. PubMed ID: 20435237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Famotidine in gastroesophageal reflux disease (GERD).
    Wesdorp IC
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():24-6. PubMed ID: 1577391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double-blind, placebo-controlled study of ranitidine for gastroesophageal reflux symptoms during pregnancy.
    Larson JD; Patatanian E; Miner PB; Rayburn WF; Robinson MG
    Obstet Gynecol; 1997 Jul; 90(1):83-7. PubMed ID: 9207819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.